BioRN Leads InnoLife Consortium to Success in the Competition Healthy Living and Active Ageing of the EIT
BioRN is a member of the consortium InnoLife, which has won the call for the Knowledge and Innovation Community (KIC) Healthy Living and Active Ageing (EIT Health) of the European Institute for Innovation and Technology (EIT). With a grant volume of up to €700 million and a total project volume of more than €2 billion, this is one of the largest publicly funded initiatives in the health sector worldwide.
Among the 50 core partners and additional 90 associate organisations from nine EU countries are, among others, Roche Diagnostics in Mannheim, AbbVie in Ludwigshafen and the University of Heidelberg as representatives of the BioRN cluster as well as major institutions and companies from the BioRN partner regions Cambridge in the United Kingdom and Leuven in Belgium (Health Axis Europe Alliance). In the next 7 years the consortium partners will cooperate as a Knowledge and Innovation Community (KIC) with the aim of delivering innovative products, services and concepts that will improve quality of life and contribute to the sustainability of healthcare across Europe. During the application phase the German partners of the consortium, including the BioRN cluster in Heidelberg as well as the top regions BioM in Munich, Medical Valley in Erlangen and BIO.NRW with its locations in Cologne and Aachen, had already agreed that the EIT Health projects would be coordinated from Heidelberg.
BioRN managing director Dr Christian Tidona made the following statement on winning the KIC call: “The successful initiation of this worldwide unique large-scale project is the direct result of the investment of the German Federal Government, the State of Baden-Württemberg and the regional partners in our BioRN leading-edge cluster. This opportunity for internationalization and active participation from major local institutions and companies in the health sector will sustainably strengthen our Rhine-Neckar metropolitan region.”
Related News
-
News Patients vs Pharma – who will the Inflation Reduction Act affect the most?
The Inflation Reduction Act brought in by the Biden administration in 2022 aims to give better and more equitable access to healthcare in the USA. However, pharma companies are now concerned about the other potential costs of such legislation. -
News CPHI Podcast Series: What does the changing US Pharma market mean for industry and patients alike?
In this week's episode of the CPHI Podcast Series Lucy Chard, Digital Editor for CPHI Online is joined by James Manser to discuss the political and market changes in the US pharma field. -
News CPHI Barcelona Annual Report illuminates industry trends for 2024
The CPHI Annual Survey comes into it’s 7th year to report on the predicted trends for 2024. Over 250 pharma executives were asked 35 questions, with their answers informing the industry landscape for the next year, spanning all major pharma marke... -
News Which 10 drugs are open to price negotiation with Medicare in the USA?
The Centres for Medicare & Medicaid Services, under the Biden administration in the USA, has released a list of the 10 drugs that will be open to price negotiations as part of the new legislation under the Inflation Reduction Act (IRA). -
News EU Medical Devices Regulation causes unintended disappearances of medical devices for children, doctors state
Doctor groups and associations have appealed to the EU to correct the EU Medical Devices Regulation law that may cause unintended shortages of essential drug and medical devices for children and rare disease patients. -
News 10 Major Drug Approvals So Far in 2023
Last year, 37 novel drugs were approved by the FDA, this was a high number for such a category, and covered many fields including oncology, demonstrating how promising further research is, and how it is only continuing to build. To date, there are alre... -
News Detecting Alzheimer's disease with a simple lateral flow test
A novel rapid diagnostic test for early-stage Alzheimer's disease has been developed using a biomarker binder from Aptamer Group along with technology from Neuro-Bio, the neurodegenerative disease experts. -
News CPHI Podcast Series: outsourcing and manufacturing trends
Listen to the CPHI Podcast Series this June to hear Gil Roth of the PBOA speak with Digital Editor Lucy Chard about the biggest trends and topics to watch in pharma outsourcing and manufacturing at the minute.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance